S
ABBV icon

Seeyond’s AbbVie ABBV Stock Holding History

Seeyond’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$4.58M Sell
28,318
-4,703
-14% -$721K 0.44% 49
2022
Q3 		$4.43M Buy
33,021
+11,120
+51% +$1.6M 0.53% 30
2022
Q2 		$3.35M Sell
21,901
-4,041
-16% -$617K 0.38% 54
2022
Q1 		$4.21M Sell
25,942
-26,924
-51% -$3.91M 0.42% 41
2021
Q4 		$7.16M Sell
52,866
-12,334
-19% -$1.46M 0.66% 14
2021
Q3 		$7.03M Sell
65,200
-9,375
-13% -$1.07M 0.68% 16
2021
Q2 		$8.4M Sell
74,575
-6,288
-8% -$708K 0.78% 15
2021
Q1 		$8.75M Buy
80,863
+13,282
+20% +$1.42M 0.88% 12
2020
Q4 		$7.24M Buy
67,581
+3,702
+6% +$356K 0.75% 17
2020
Q3 		$5.59M Buy
63,879
+29,311
+85% +$2.76M 0.61% 26
2020
Q2 		$3.39M Buy
34,568
+14,349
+71% +$1.26M 0.38% 41
2020
Q1 		$771K Sell
20,219
-4,339
-18% -$370K 0.11% 274
2019
Q4 		$2.17M Sell
24,558
-941
-4% -$78.1K 0.23% 136
2019
Q3 		$1.93M Sell
25,499
-2,013
-7% -$138K 0.2% 164
2019
Q2 		$2M Buy
27,512
+4,841
+21% +$381K 0.21% 164
2019
Q1 		$1.83M Buy
22,671
+18,274
+416% +$1.49M 0.17% 196
2018
Q4 		$405K Buy
+4,397
New +$387K 0.06% 406

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Seeyond's ABBV Position: Q4 2022 in Review

Seeyond reduced its AbbVie (ABBV) stake by 14% in Q4 2022, selling an estimated $721K and leaving 28,318 shares worth $4.58M. The position accounts for 0.44% of the portfolio, ranked #49.

Seeyond first reported a position in ABBV in Q4 2018 and has held it in 17 quarters since. The position peaked at $8.75M in Q1 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Seeyond held 28,318 shares of AbbVie worth $4.58M as of Q4 2022.
  • Seeyond sold 4,703 AbbVie shares in Q4 2022, an estimated $721K.
  • AbbVie made up 0.44% of Seeyond's portfolio in Q4 2022, its #49 holding.
  • Seeyond first reported a position in AbbVie in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's AbbVie position peaked at $8.75M in Q1 2021.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.